英国的GenInCode与家庭心脏基金会和UT Southwestern合作,在美国医疗机构实施LIPID inCode测试,以早期检测和治疗家族性高胆固醇血症. UK's GenInCode partners with Family Heart Foundation and UT Southwestern to implement LIPID inCode test for early detection and treatment of familial hypercholesterolemia in US healthcare settings.

GENinCode Plc是一家英国遗传学公司,与家庭心脏基金会和UT西南部公司合作,在美国医疗保健机构实施家庭高胆固醇(FH)诊断方法的LIPID InCode测试。 GENinCode Plc, a UK genetics firm, has partnered with the Family Heart Foundation and UT Southwestern to implement the LIPID inCode test for diagnosing familial hypercholesterolemia (FH) in US healthcare settings. 在国防部赠款的资助下,该倡议旨在加强对FH的早期发现和治疗,FH是一种与高胆固醇和心血管疾病风险增加有关的遗传性疾病。 Funded by a Department of Defense grant, the initiative aims to enhance early detection and treatment of FH, a hereditary condition linked to high cholesterol and increased cardiovascular disease risk. 合作还强调家庭筛查,以查明有风险的个人。 The collaboration also emphasizes family screening to identify at-risk individuals.